Efficacy of Acarbose and Metformin in Newly Diagnosed Type 2 Diabetes Patients Stratified by HbA1c Levels

Journal of Diabetes - United States
doi 10.1111/1753-0407.12337
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

MARCH2: Comparative Assessment of Therapeutic Effects of Acarbose and Metformin in Newly Diagnosed Type 2 Diabetes Patients

PLoS ONE
Multidisciplinary
2014English

Largest Reported 3 Month Drop in HbA1c for a Newly Diagnosed Patient With Type 2 Diabetes

Journal of Endocrinology and Thyroid Research
2018English

Predicting Chronic Comorbid Conditions of Type 2 Diabetes in Newly-Diagnosed Diabetic Patients

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

Dynamic Thiol/Disulfide Homeostasis in Patients With Newly Diagnosed Type 2 Diabetes Mellitus

Endocrine Abstracts
2015English

A Randomized, Open Label, Comparative Study of Biotin as an Add-On Therapy to Metformin vs Metformin Alone in Newly Diagnosed Type 2 Diabetes Mellitus Patients

IOSR Journal of Dental and Medical Sciences
2016English

Efficacy of Self Monitoring of Blood Glucose in Patients With Newly Diagnosed Type 2 Diabetes (ESMON Study): Randomised Controlled Trial

BMJ
2008English

High Prevalence of the Metabolic Syndrome Among Newly Diagnosed Type 2 Diabetes Patients in Denmark

Endocrine Abstracts
2013English

The Level of Netrin-1 Is Decreased in Newly Diagnosed Type 2 Diabetes Mellitus Patients

BMC Endocrine Disorders
MedicineEndocrinologyMetabolismDiabetes
2016English

Diabetic Peripheral Neuropathy and Sudomotor Dysfunction in Saudi Patients With Newly Diagnosed Type 2 Diabetes Mellitus

Journal of Diabetes, Metabolic Disorders & Control
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy